To recapitulate the effect of NMD activity in the outcome of tumor progression, we generated different tumor cell lines with their NMD machinery compromised by blocking key NMD factors -SMG1, UPF1, UPF2- via CRISPR. The gene discussed is PLA1A; the disease is neoplasm.